DMG MORI (GIL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jun, 2025Executive summary
Order intake declined 13% year-over-year to €2,256.6m; sales revenues fell 11% to €2,228.3m.
EBIT rose 7% to €245.4m, with EBIT margin improving to 11.0% from 9.2% year-over-year.
EAT from continuing operations was €179.4m; EAT from discontinued operations was €-91.9m due to Russian asset loss.
Free cash flow increased 25% to €117.0m; equity ratio improved to 57.0%.
All adjusted full-year forecasts were achieved despite challenging global conditions.
Financial highlights
EBITDA increased 7% to €326.0m; EBT up 7% to €254.7m year-over-year.
Net income (EAT) dropped 46% to €87.5m, mainly due to the discontinued Russian operations.
Sales backlog at year-end was €1,452.0m, down 5% from prior year.
Cash and cash equivalents at year-end were €136.2m; net financial liabilities at €-115.2m.
Market capitalization at year-end was €3.59bn; EPS from continuing operations was €2.16.
Outlook and guidance
2025 order intake forecast: €2.4–2.5bn; sales revenues: €2.2–2.3bn.
EBIT expected between €150–160m; free cash flow between €110–130m.
Segment guidance: Machine Tools sales €1.2–1.3bn, Industrial Services €1.0–1.1bn.
Planned investments of ~€65m, R&D expenses to remain stable at ~€88m.
Effects of possible compensation for Russian asset expropriation not included in forecasts.
Latest events from DMG MORI
- Order intake rose 4% year-over-year, but sales and EBIT fell amid ongoing global uncertainties.GIL
Q4 202519 Mar 2026 - Order intake steady, but sales and earnings fell, leading to a downward revision in guidance.GIL
Q3 202530 Oct 2025 - Order intake and sales fell, but profitability and 2025 guidance remain solid.GIL
Q2 20251 Aug 2025 - EBIT margin improved despite lower sales and order intake, with 2024 guidance revised downward.GIL
Q3 202413 Jun 2025 - Profitability rose despite lower sales, with a one-time Russian loss driving a group net loss.GIL
Q2 202413 Jun 2025 - Order intake and sales dropped 15% year-over-year, but full-year guidance is reaffirmed.GIL
Q1 20256 Jun 2025